IL-36R Archives - Medical Conferences

Subcutaneous spesolimab for GPP flare prevention

Presented By

Prof. Bruce Strober, Yale University School of Medicine, CT, USA

Trial

Effisayil 2

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:32

Spesolimab appears successful in hidradenitis suppurativa

Presented By

Prof. Afsaneh Alavi, Mayo Clinic, MN, USA

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:12

Rapid pustule and skin clearance with IL-36 receptor inhibitor spesolimab

Presented By

Prof. Hervé Bachelez, Hôpital Saint-Louis, France

Trial

Phase 2, Effisayil 1

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:04

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com